D. E. Shaw & Co., Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$2,571,000
-28.4%
21,714
-28.6%
0.00%
-33.3%
Q4 2020$3,592,000
-12.9%
30,417
-18.0%
0.00%
-25.0%
Q3 2020$4,124,000
+41.1%
37,107
+29.7%
0.00%
+33.3%
Q2 2020$2,922,000
-21.4%
28,601
-17.0%
0.00%
-50.0%
Q1 2020$3,719,000
-38.3%
34,458
-33.5%
0.01%
-14.3%
Q4 2019$6,027,000
-3.0%
51,785
-4.6%
0.01%
-12.5%
Q3 2019$6,214,000
+21.9%
54,285
+1.5%
0.01%
+33.3%
Q2 2019$5,096,000
-53.1%
53,472
-55.1%
0.01%
-57.1%
Q1 2019$10,867,000
+12.1%
119,087
-6.7%
0.01%
+7.7%
Q4 2018$9,691,000
+20.6%
127,660
+27.1%
0.01%
+30.0%
Q3 2018$8,036,000
-54.9%
100,447
-44.0%
0.01%
-56.5%
Q2 2018$17,827,000
+109.6%
179,473
+70.9%
0.02%
+91.7%
Q1 2018$8,506,000
-41.1%
105,014
-42.7%
0.01%
-40.0%
Q4 2017$14,436,000
+59.4%
183,269
+86.8%
0.02%
+42.9%
Q3 2017$9,055,00098,1340.01%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders